LYB
39
3
LEG
27
-2
AMZN
64
3
COF
69
9
ALL
43
5
CVX
32
3
AFL
44
3
STX
56
3
CFG
78
20
CL
45
-5
SBUX
32
-3
MMC
60
5
NKE
25
-5
MTCH
59
4
C
64
10
PNW
73
7
MPC
44
8
LEN
48
-5
CCL
86
4
ALLE
46
2
LYB
39
3
LEG
27
-2
AMZN
64
3
COF
69
9
ALL
43
5
CVX
32
3
AFL
44
3
STX
56
3
CFG
78
20
CL
45
-5
SBUX
32
-3
MMC
60
5
NKE
25
-5
MTCH
59
4
C
64
10
PNW
73
7
MPC
44
8
LEN
48
-5
CCL
86
4
ALLE
46
2
Financhill
Back

CareTrust REIT 10K Form

Buy
59

CTRE
CareTrust REIT

Last Price:
29.48
Seasonality Move:
2.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CTRE News And Ratings

See the #1 stock for the next 7 days that we like better than CTRE

CTRE Financial Statistics

Sales & Book Value

Annual Sales: $198.6M
Cash Flow: $64.38M
Price / Cash Flow: 21
Annual Sales: $14.15
Price / Book: 2.39

Profitability

EPS (TTM): 0.72000
Net Income (TTM): $99.24M
Gross Margin: $189.01M
Return on Equity: 5.79%
Return on Assets: 4.2%

CareTrust REIT Earnings Forecast

Key CareTrust REIT Financial Ratios

  • The Gross Profit Margin over the past 12 years for CTRE is 95.17%.
  • The Selling, General & Administrative Expenses for CTRE have been equal to 10.52% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 76.08% of Operating Income.
  • The Net Earning history of CTRE is 27.06% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 5 years.

CareTrust REIT Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care REITs
Sector: Real Estate
Current Symbol: CTRE
CUSIP: 14174T
Website: caretrustreit.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 3.96
Quick Ratio: 3.8

Price-to-Earnings

Trailing P/E Ratio: 61.7
Forward P/E Ratio: 23.55

CTRE Technical Analysis vs Fundamental Analysis

Buy
59
CareTrust REIT (CTRE) is a Buy

Is CareTrust REIT a Buy or a Sell?

  • CareTrust REIT stock is rated a Buy
    The current CareTrust REIT [CTRE] share price is $29.49. The Score for CTRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.